# 9-valent CRM 197 Pneumococcal

> **NCT00133549** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 180 (actual)

## Conditions studied

- Pneumococcal Infection

## Interventions

- **DRUG:** Placebo
- **BIOLOGICAL:** PNU-IMUNE®23
- **BIOLOGICAL:** Nine-valent pneumococcal conjugate (PNCRM9)

## Key facts

- **NCT ID:** NCT00133549
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2002-12
- **Final completion:** 2002-12
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2014-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133549, "9-valent CRM 197 Pneumococcal". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00133549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*